Published: Apr, 2017
The global veterinary drugs market is largely consolidated with top ten companies holding more than 70% market, says a new report by Transparency Market Research (TMR). In 2015, the market was led by Merck Animal Health, Merial Animal Health, Bayer Animal Health, Zoetis Inc., and Elanco Animal Health reflecting a highly consolidated competitive landscape. Despite this, fierce rivalry exists among top players in the global market for veterinary drugs.
In a bid to enhance brand image, several players are engaging in direct assistance as opposed to mass marketing strategies. Besides this, companies are offering attractive discounts on multi-product purchases.
TMR forecasts the global veterinary drugs market to display a CAGR of 5.1% from 2016 to 2024. At this pace, the valuation of the market is projected to reach US$26.7 bn by 2024 increasing from US$17.2 bn in 2015.
Livestock Animal Segment to hold Leading Share in Market
In terms of animal type, the market is divided into livestock animal and companion animal. Between the two, livestock animal held the leading share in 2015 due to an ever-increasing demand for poultry meat and high quality protein. The segment of companion animal is expected to display robust growth as well over the forecast period. This is due to increasing pet ownership and increasing expenditure on their well-being.
By product, the segments of the market are anti-infective, anti-inflammatory parasiticides, and others. In 2015, anti-infective held the leading share gaining from the increased demand for zoonotic diseases. Nevertheless, over the forecast period from 2016 to 2024, parasiticides is expected to display higher growth than other segments. The segment is expected to display a CAGR of 6.1% between 2016 and 2024 thereby emerging as the most attractive product segment.
By geography, the veterinary drugs market is segmented into the regions of North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa. In 2015, North America stood as the leading regional market accounting for 31% of the global market. The region is expected to stay at the fore until the end of the forecast period in 2024. The high number of pet ownership is the major factor boosting the growth of this regional market.
Over the report’s forecast period, Asia Pacific and Latin America are expected to contribute substantial revenues to the overall market. In these regions, the increasing incidence of infectious diseases are fuelling the demand for veterinary drugs.
Increasing Tendency for Higher Spending on Companion Animals Drives Demand for Veterinary Drugs
The growth of the veterinary drugs market is driven by increasing pet ownership and a high spending on their health and well-being. In addition, innovations and advancements for surgical procedures for companion animals is also boosting the growth of this market. Due to increased consideration for the health and well-being of companion animals, their life expectancy has increased. Veterinarians and pet owners are looking to provide better nutrition to companion animals which may be in the form of nutritional supplements and animal wellness drugs. Besides this, the introduction of novel therapeutics that help companion animal combat zoonotic diseases is aiding the growth of veterinary drugs market.
With the increasing incidence of zoonotic and vector-borne diseases the market is expected to be benefitted over the forecast period. The market is also expected to be benefitted from increasing demand for high quality meat that requires livestock to be free of diseases.
The review presented is based on findings of Transparency Market Research report, titled “Veterinary Drugs Market (Product Type - Anti-infective, Anti-inflammatory, and Parasiticides; Animal - Companion and Livestock; Route of Administration - Oral, Parenteral, and Topical) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”
The global veterinary drugs market is segmented as follows:
Global Veterinary Drugs Market, by Product
Global Veterinary Drugs Market, by Animal
Global Veterinary Drugs Market, by Route of Distribution
Global Veterinary Drugs Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC countries
- South Africa
- Rest of Middle East & Africa
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453